Liminatus Pharma, Inc. (LIMN)

Liminatus Pharma Statistics

Total Valuation

LIMN has a market cap or net worth of $33.56 million. The enterprise value is $33.66 million.

Market Cap	33.56M
Enterprise Value	33.66M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

LIMN has 27.06 million shares outstanding. The number of shares has increased by 28.19% in one year.

Current Share Class	27.06M
Shares Outstanding	27.06M
Shares Change (YoY)	+28.19%
Shares Change (QoQ)	-10.43%
Owned by Insiders (%)	33.66%
Owned by Institutions (%)	0.76%
Float	5.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.17

Current Ratio	0.17
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.55

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	24.31%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.38
52-Week Price Change	n/a
50-Day Moving Average	2.06
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.71
Average Volume (20 Days)	565,021

Short Selling Information

The latest short interest is 276,244, so 1.02% of the outstanding shares have been sold short.

Short Interest	276,244
Short Previous Month	395,921
Short % of Shares Out	1.02%
Short % of Float	4.97%
Short Ratio (days to cover)	0.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.09M
Pretax Income	-1.05M
Net Income	-1.05M
EBITDA	n/a
EBIT	-2.09M
Earnings Per Share (EPS)	-$0.01

Balance Sheet

The company has $1.34 million in cash and $1.44 million in debt, giving a net cash position of -$104,278 or -$0.00 per share.

Cash & Cash Equivalents	1.34M
Total Debt	1.44M
Net Cash	-104,278
Net Cash Per Share	-$0.00
Equity (Book Value)	-8.81M
Book Value Per Share	-0.34
Working Capital	-8.73M

Cash Flow

Operating Cash Flow	-9.32M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LIMN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.19%
Shareholder Yield	-28.19%
Earnings Yield	-3.11%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1